" Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Beh çet's Disease "
Condition: Behcet's Uveitis Interventions: Drug: Adalimumab; Drug: Tocilizumab Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 25, 2023 Category: Research Source Type: clinical trials